Skip to main content
OpenTrials
Completed

NCT Number: NCT04343404

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Respiratory Distress Syndrome Lung Diseases Respiration Disorders Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient over the age of 18;
  • Diagnostic COVID-19 by RT-PCR;
  • Hospitalisation in resuscitation for the management of complications related to COVID-19
  • Implanted ECMO-VV during hospitalisation;
  • Patient agreeing to participate in the study

Exclusion criteria

  • Sujet under guardianship or trusteeship
  • Sujet under safeguard of justice

Treatment and study plan

Primary outcomes

  1. Retrospective description of COVID-19 patients receiving respiratory ECMO-VV supplementation and what happens to them

    Time frame: Files analysed retrospectily from March 1st, 2020 to April 15, 2020 will be examined

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

Acronym: ECMO-COVID-19

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 13, 2020
Registry last updated
Jun 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.